Bioxyne (ASX:BXN)
ASX announcement history & article coverage
Transparent by design.
Announcments by Bioxyne (ASX:BXN) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 3H
Appendix 2A
Change of Name - BLS Pharmaceuticals Limited
Application for quotation of securities - BXN
Results of Meeting
Bioxyne General Meeting 19.6.2026
Initial Director's Interest Notice
New Independent Director to Strengthen Board
Investor Presentation - Coffee Microcaps Webinar
Application for quotation of securities - BXN
Consolidation/Split - BXN
Letter to Shareholders re General Meeting Notice
Notice of General Meeting/Proxy Form
Bioxyne to hold General Meeting on June 19 for name change and 10:1 share consolidation
Application for quotation of securities - BXN
Change of Director's Interest Notice
Secures $50m Exclusive German Supply Agreement with ADREX
Bioxyne inks $50 million exclusive German supply deal with ADREXpharma
Expands LATAM Footprint First Supply Agreement Costa Rica
Bioxyne expands LATAM supply agreement to include medicinal cannabis flower in Costa Rica
Quarterly Activities/Appendix 4C Cash Flow Report
Bioxyne posts record Q3 revenue of A$21.3m, secures key manufacturing deals, and confirms FY26 guidance
Application for quotation of securities - BXN